Ligne de temps

Ruby Alonso
Chercheur(euse) Contractuel(le)
15 août 2025
publication
Reprogramming RIPK3-induced cell death in malignant B cells promotes immune-mediated tumor control.
Lire plus01 avr. 2024
publication
Anti-PD-1 therapy triggers Tfh cell-dependent IL-4 release to boost CD8 T cell responses in tumor-draining lymph nodes.
Lire plus25 mars 2024
news
New publication – Anti-PD-1 therapy triggers Tfh cell–dependent IL-4 release to boost CD8 T cell responses in tumor-draining lymph nodes
Lire plus01 juil. 2023
publication
Tumor-intrinsic sensitivity to the pro-apoptotic effects of IFN-γ is a major determinant of CD4+ CAR T-cell antitumor activity.
Lire plus05 juin 2023
news
New publication – Tumor-intrinsic sensitivity to the pro-apoptotic effects of IFN-γ is a major determinant of CD4+ CAR T-cell antitumor activity
Lire plus11 mai 2015